Clinical Trials Browser

Phase NA × Unknown × Simpson-Golabi-Behmel syndrome × Clear all

NCT04728139 2022-01-13

Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients

Phase NA Unknown

Gastrointestinal

Simpson-Golabi-Behmel syndrome, Colorectal Neoplasms